• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Antacid Market

    ID: MRFR/Pharma/7443-HCR
    100 Pages
    Garvit Vyas
    October 2025

    Antacid Market Research Report By Type (Liquid Antacids, Tablet Antacids, Powder Antacids, Chewable Antacids), By Active Ingredient (Aluminum Hydroxide, Magnesium Hydroxide, Sodium Bicarbonate, Calcium Carbonate, Potassium Citrate), By Application (Immediate Relief, Long-Term Relief, Heartburn, Indigestion, Acid Reflux), By Distribution Channel (Pharmacies, Online Retailers, Supermarkets, Convenience Stores, Healthcare Professionals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Antacid Market Infographic
    Purchase Options

    Antacid Market Summary

    The global antacid market is projected to grow from 18.99 USD billion in 2024 to 25.74 USD billion by 2035.

    Key Market Trends & Highlights

    Antacid Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 3.06 percent from 2025 to 2032.
    • By 2035, the antacid market is anticipated to reach a valuation of 26.5 USD billion, indicating robust growth.
    • In 2024, the market valuation stands at 19.0 USD billion, reflecting a solid foundation for future expansion.
    • Growing adoption of antacids due to increasing prevalence of gastrointestinal disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 18.99 (USD Billion)
    2035 Market Size 25.74 (USD Billion)
    CAGR (2025-2035) 2.80%

    Major Players

    GlaxoSmithKline, Bayer, Teva Pharmaceutical Industries Ltd., Johnson Johnson Consumer Inc., Merck Co., Inc., Procter Gamble Company, Mentholatum Company, Reckitt Benckiser, Daiichi Sankyo Company, Limited, AstraZeneca Plc, Sanofi Aventis, Abbott Laboratories, Novartis, Boehringer Ingelheim GmbH

    Antacid Market Trends

    The demand for antacids is primarily driven by the increasing prevalence of gastrointestinal disorders such as heartburn, acidity, and indigestion. Sedentary lifestyles, irregular eating habits, and stress all contribute to digestive issues, fueling the market growth. Moreover, the rising awareness about the importance of gut health and the availability of over-the-counter antacids further stimulate market expansion.

    The market presents opportunities for innovation in delivery formats, such as chewable tablets, liquids, and effervescent powders. Additionally, the development of antacids with natural ingredients and herbal remedies offers potential growth avenues. Exploring the potential of antacids in pet care and targeting specific demographics, such as the geriatric population, can also uncover new market segments.

    The antacid market has witnessed a shift towards antacids with a combination of ingredients, such as magnesium, calcium, and aluminum, as they provide faster and more comprehensive relief. Furthermore, the growing popularity of antacids containing prebiotics and probiotics has emerged as a trend, catering to consumers seeking holistic solutions for digestive health.

     

    The increasing prevalence of gastrointestinal disorders, coupled with a growing awareness of preventive healthcare, appears to drive the demand for antacid products globally.

    U.S. Food and Drug Administration (FDA)

    Antacid Market Drivers

    Innovations in Antacid Formulations

    Innovations in antacid formulations are reshaping the Global Antacid Market Industry. Manufacturers are increasingly focusing on developing advanced formulations that offer quicker relief and improved efficacy. For instance, the introduction of effervescent tablets and chewable forms caters to diverse consumer preferences, enhancing the overall user experience. These innovations not only attract new consumers but also retain existing ones seeking enhanced solutions for their digestive discomfort. As the market evolves, the emphasis on product differentiation through innovation is likely to play a crucial role in sustaining growth, particularly as the industry adapts to changing consumer demands.

    Expansion of Retail Distribution Channels

    The expansion of retail distribution channels significantly influences the Global Antacid Market Industry. With the proliferation of pharmacies, supermarkets, and online platforms, consumers have greater access to antacid products. This accessibility not only enhances consumer convenience but also encourages impulse purchases. Retailers are increasingly stocking a diverse range of antacid formulations, catering to varying consumer preferences. The ease of obtaining these products is likely to contribute to a steady growth trajectory, with a projected compound annual growth rate (CAGR) of 3.06% from 2025 to 2035. This trend underscores the importance of distribution strategies in shaping market dynamics.

    Growing Consumer Awareness of Digestive Health

    Consumer awareness regarding digestive health is on the rise, leading to increased utilization of antacids. Educational campaigns and health initiatives have highlighted the importance of maintaining gastrointestinal well-being, prompting individuals to seek preventive measures. This trend is particularly evident in developed regions, where consumers are more inclined to invest in over-the-counter solutions for digestive issues. The Global Antacid Market Industry benefits from this shift, as consumers prioritize products that promote digestive comfort. As a result, the market is expected to grow steadily, with projections indicating a value of 26.5 USD Billion by 2035, driven by informed purchasing decisions.

    Rising Prevalence of Gastroesophageal Reflux Disease

    The increasing incidence of gastroesophageal reflux disease (GERD) globally drives the demand for antacids. GERD affects a significant portion of the population, with estimates suggesting that approximately 20% of adults experience symptoms at least once a week. This growing prevalence necessitates effective management strategies, thereby bolstering the Global Antacid Market Industry. As individuals seek relief from discomfort, the market is projected to reach 19.0 USD Billion in 2024, reflecting a robust response to this health concern. The rising awareness of GERD and its complications further emphasizes the need for accessible antacid solutions.

    Aging Population and Increased Healthcare Expenditure

    The aging population worldwide contributes to the growth of the Global Antacid Market Industry. As individuals age, they often experience a higher incidence of gastrointestinal disorders, including acid reflux and heartburn. This demographic shift is accompanied by increased healthcare expenditure, as older adults seek effective treatments for their ailments. Governments and healthcare systems are recognizing the importance of addressing these issues, leading to greater availability of antacid products. Consequently, the market is poised for expansion, with projections indicating a value of 19.0 USD Billion in 2024. The intersection of demographic trends and healthcare spending underscores the market's potential.

    Market Segment Insights

    Antacid Market Type Insights

    The Antacid Market is divided by type into liquid antacids, tablet antacids, powder antacids and chewable antacids. Liquid antacids are by far the most used type, as they are the easiest to use, conveniently available and do not require any special conditions to be administered. They are always over-the-counter preparations and are most popular among consumers who suffer from frequent heartburn or indigestion. Tablet antacids are a more convenience-packed version of the liquid Biospy ones with the same active ingredients.

    Tablets are used for more severe heartburns and indigestion issues with higher concentrations and possible prescription forms. Different from table antacids powder ones are, although more rare, also used and effective in neutralizing stomach acid. Powder antacids are usually mixed with water. Chewable antacids are much more convenient and preferred especially for those who do not like taking something liquid. They are offered in various tastes and can also be aimed at children as well as grown-ups with difficulties in pill- and tablet-swallowing.

    This is first of all because of the rising prevalence of gastrointestinal or related diseases, such as heartburn and indigestion, and, secondly, the growth of OTC drugs and increased awareness of gut health.

    Antacid Market Active Ingredient Insights

    The Antacid Market segmentation by Active Ingredient comprises Aluminum Hydroxide, Magnesium Hydroxide, Sodium Bicarbonate, Calcium Carbonate, and Potassium Citrate. Among these, Aluminum Hydroxide and Magnesium Hydroxide collectively accounted for over 60% of the market revenue in 2023. Aluminum Hydroxide, being the most widely used antacid, is expected to maintain its dominance throughout the forecast period. The growing prevalence of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD) is anticipated to drive the demand for Aluminum Hydroxide-based antacids. Additionally, Magnesium Hydroxide is gaining popularity due to its ability to neutralize stomach acid and provide fast relief from heartburn and indigestion.

    The growing awareness about the benefits of antacids is expected to fuel the growth of the Antacid Market in the coming years.

    Antacid Market Application Insights

    The Antacid Market segmentation by Application includes Immediate Relief, Long-Term Relief, Heartburn, Indigestion, and Acid Reflux. The Immediate Relief segment accounted for the largest market share, around USD 4.5 billion in 2023, and is anticipated to grow at a CAGR of 2.8% during the forecast period. The Long-Term Relief segment is projected to witness a CAGR of 3.2% over the forecast period. Heartburn and Indigestion are expected to grow at a CAGR of 2.9% and 2.7%, respectively, during the forecast period. Acid Reflux is projected to grow at a CAGR of 2.6%.

    The growth of the Antacid Market is primarily attributed to the increasing prevalence of gastrointestinal disorders, such as acid reflux and heartburn, along with the growing awareness of antacids among consumers.

    Antacid Market Distribution Channel Insights

    The distribution channel segment plays a crucial role in the Antacid Market, shaping market dynamics and influencing revenue generation. Pharmacies emerged as the dominant distribution channel, accounting for a significant share of the market in 2023. Their extensive reach, accessibility, and trusted reputation among consumers drive their dominance. Online retailers are rapidly gaining ground, leveraging e-commerce platforms to offer convenience, competitive pricing, and a wide product range. Supermarkets and convenience stores cater to impulse purchases and provide easy access to antacids for immediate relief.

    Healthcare professionals, including doctors and pharmacists, serve as valuable distribution channels, providing expert advice and recommendations to patients. Understanding the strengths and preferences of each distribution channel is essential for manufacturers to optimize their strategies and maximize market penetration.

    Get more detailed insights about Antacid Market

    Regional Insights

    The Antacid Market segmentation by region offers valuable insights into the market's geographic performance. North America held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period. The region's large population, high disposable income, and prevalence of gastrointestinal disorders contribute to its significant market size. Europe is another key market, driven by increasing healthcare expenditure and rising awareness about antacid usage. The Asia-Pacific region is expected to witness substantial growth, owing to the increasing prevalence of digestive issues, growing population, and expanding healthcare infrastructure.

    South America and the Middle East and Africa (MEA) regions are also expected to contribute to the overall market growth, albeit at a slower pace.

    Antacid Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in Antacid Market industry are constantly innovating and developing new products to meet the evolving needs of consumers. Leading Antacid Market players are focusing on expanding their global presence through acquisitions and partnerships. The Antacid Market development is being driven by the increasing prevalence of gastrointestinal disorders and the growing demand for over-the-counter medications. The Antacid Market Competitive Landscape is characterized by the presence of both global and regional players. Among the leading players in the Antacid Market, GlaxoSmithKline holds a significant market share. The company offers a wide range of antacid products under the brand name Tums.

    Tums is one of the most recognized and trusted antacid brands in the world. GlaxoSmithKline has a strong distribution network and a loyal customer base. The company is continuously investing in research and development to develop new and innovative antacid products. One of the key competitors in the Antacid Market is Bayer. The company offers a range of antacid products under the brand name Alka-Seltzer. Alka-Seltzer is a well-known and popular antacid brand. Bayer has a strong presence in both developed and emerging markets. The company is focusing on expanding its market share through product innovation and strategic acquisitions.

    Key Companies in the Antacid Market market include

    Industry Developments

    • Q2 2024: TUMS® Launches New TUMS+ Heartburn+Sleep Support Chewable Tablets TUMS®, a leading antacid brand, announced the launch of TUMS+ Heartburn+Sleep Support, a chewable tablet combining antacid relief with melatonin to address both heartburn and occasional sleeplessness. The product became available nationwide in the United States in April 2024.
    • Q2 2024: GSK Consumer Healthcare Announces U.S. Launch of New Liquid Antacid Under Tums Brand GSK Consumer Healthcare introduced a new liquid antacid formulation under its Tums brand, expanding its product portfolio to address consumer demand for alternative antacid delivery formats. The product was made available in major U.S. retail outlets in May 2024.
    • Q2 2024: Dr. Reddy’s Laboratories Launches Famotidine Tablets USP, 20 mg and 40 mg, in the U.S. Market Dr. Reddy’s Laboratories announced the launch of Famotidine Tablets USP, 20 mg and 40 mg, an over-the-counter antacid product, in the United States following approval from the U.S. Food and Drug Administration in April 2024.
    • Q3 2024: Sanofi Appoints New Head of Consumer Healthcare Division Sanofi announced the appointment of a new executive to lead its Consumer Healthcare division, which includes the company’s antacid brands, as part of a broader leadership restructuring in July 2024.
    • Q3 2024: Perrigo Opens New Manufacturing Facility for OTC Antacids in Michigan Perrigo Company plc inaugurated a new manufacturing facility in Michigan dedicated to the production of over-the-counter antacid products, aiming to increase capacity and meet growing demand in North America in August 2024.
    • Q3 2024: Reckitt Benckiser Launches Gaviscon Dual Action Chewable Tablets in Canada Reckitt Benckiser announced the Canadian launch of Gaviscon Dual Action Chewable Tablets, expanding its antacid product line in North America in July 2024.
    • Q4 2024: GSK Receives FDA Approval for New Pepcid Complete Formulation GSK received U.S. FDA approval for a new formulation of Pepcid Complete, an over-the-counter antacid, in October 2024, enabling the company to offer enhanced acid relief options to consumers.
    • Q4 2024: Bayer Sells Antacid Brand Talcid to Stada Arzneimittel Bayer AG completed the sale of its antacid brand Talcid to Stada Arzneimittel as part of a portfolio optimization strategy in November 2024.
    • Q1 2025: Sun Pharma Launches Generic Ranitidine Tablets in U.S. Market Sun Pharmaceutical Industries announced the launch of generic Ranitidine Tablets, an antacid product, in the U.S. market in January 2025 following regulatory clearance.
    • Q1 2025: Procter & Gamble Expands Prilosec OTC Production Capacity in Ohio Procter & Gamble announced the expansion of its Prilosec OTC production facility in Ohio to meet increased demand for over-the-counter antacid products in February 2025.
    • Q2 2025: Takeda and Alkem Laboratories Announce Strategic Partnership for Antacid Distribution in Asia Takeda and Alkem Laboratories entered into a strategic partnership to distribute Takeda’s antacid products across select Asian markets, aiming to strengthen their presence in the region in May 2025.
    • Q2 2025: Pfizer Launches New Fast-Dissolving Antacid Tablets in Europe Pfizer announced the launch of a new line of fast-dissolving antacid tablets in several European countries, targeting consumers seeking rapid relief from heartburn and indigestion in June 2025.

    Future Outlook

    Antacid Market Future Outlook

    The Global Antacid Market is projected to grow at a 2.80% CAGR from 2025 to 2035, driven by increasing consumer awareness and rising gastrointestinal disorders.

    New opportunities lie in:

    • Develop innovative formulations targeting specific demographics, such as children and the elderly. Leverage e-commerce platforms for direct-to-consumer sales, enhancing market reach. Invest in sustainable packaging solutions to attract environmentally conscious consumers.

    By 2035, the Antacid Market is expected to demonstrate robust growth, reflecting evolving consumer needs and preferences.

    Market Segmentation

    Antacid Market Type Outlook

    • Liquid Antacids
    • Tablet Antacids
    • Powder Antacids
    • Chewable Antacids

    Antacid Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Antacid Market Application Outlook

    • Immediate Relief
    • Long-Term Relief
    • Heartburn
    • Indigestion
    • Acid Reflux

    Antacid Market Active Ingredient Outlook

    • Aluminum Hydroxide
    • Magnesium Hydroxide
    • Sodium Bicarbonate
    • Calcium Carbonate
    • Potassium Citrate

    Antacid Market Distribution Channel Outlook

    • Pharmacies
    • Online Retailers
    • Supermarkets
    • Convenience Stores
    • Healthcare Professionals

    Report Scope

    Report Attribute/MetricDetails
    Market Size 202418.99(USD Billion)
    Market Size 203525.74 (USD Billion)
    Compound Annual Growth Rate (CAGR)2.80% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2018-2022
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledTeva Pharmaceutical Industries Ltd., Johnson Johnson Consumer Inc., Bayer AG, Merck Co., Inc., Procter Gamble Company, GlaxoSmithKline plc, Mentholatum Company, In, Reckitt Benckiser, Daiichi Sankyo Company, Limited, AstraZeneca Plc, Sanofi Aventis, Abbott Laboratories, Novartis, Boehringer Ingelheim GmbH
    Segments CoveredType, Active Ingredient, Application, Distribution Channel, Regional
    Key Market OpportunitiesGrowing consumer awareness, increasing prevalence of digestive disorders, expanding product portfolios, rising demand for natural and organic antacids, technological advancements
    Key Market DynamicsRising prevalence of gastroesophageal reflux disease, increasing demand for over-the-counter medications, growing awareness of antacids, technological advancements expanding the elderly population
    Countries CoveredNorth America, Europe, APAC, South America, MEA
    Market Size 202519.52 (USD Billion)

    FAQs

    What is the projected growth of the Antacid market?

    The Antacid market is the expected increase in total market value of 25.74 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Antacid market?

    Antacid market size was valued at approximately 18.99 billion USD in 2024. This figure will reach 25.74 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Antacid market?

    Antacid market is expected to grow at a CAGR of 2.8% between 2025 and 2035.

    How much will the Antacid market be worth by 2035?

    Antacid market is expected to be worth of 25.74 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Antacid market perform over the next 10 years?

    Over the next 10 years the Antacid market is expected to shift from usd billion 18.99 to 25.74 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region is expected to hold the largest market share in the Antacid Market in 2024?

    North America is expected to hold the largest market share in the Antacid Market in 2024.

    Which application segment is anticipated to drive the growth of the Antacid Market?

    The heartburn and indigestion segment is anticipated to drive the growth of the Antacid Market.

    Who are some of the key competitors in the Antacid Market?

    Some of the key competitors in the Antacid Market include GlaxoSmithKline, Johnson Johnson, Bayer, and Pfizer.

    What are the major factors contributing to the growth of the Antacid Market?

    The rising prevalence of gastroesophageal reflux disease (GERD) and other digestive disorders is a major factor contributing to the growth of the Antacid Market.

    What are the challenges faced by the Antacid Market?

    The Antacid Market faces challenges, such as the availability of over-the-counter antacids and the increasing demand for natural and organic antacids.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials